Sio Capital Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $21.3M | Buy |
+385,879
| New | +$20.9M | 3.07% | 11 |
|
|
2025
Q4 | – | Sell |
-268,873
| Closed | -$11.6M | – | 72 |
|
|
2025
Q3 | $11.6M | Buy |
+268,873
| New | +$10.5M | 2.94% | 12 |
|
|
2024
Q3 | – | Sell |
-312,000
| Closed | -$12M | – | 47 |
|
|
2024
Q2 | $12M | Buy |
312,000
+48,555
| +18% | +$2.04M | 4.53% | 8 |
|
|
2024
Q1 | $11.3M | Sell |
263,445
-307,946
| -54% | -$12.7M | 3.93% | 6 |
|
|
2023
Q4 | $21.2M | Buy |
571,391
+62,391
| +12% | +$2.24M | 5.45% | 7 |
|
|
2023
Q3 | $18.5M | Buy |
509,000
+29,468
| +6% | +$1.05M | 5.71% | 3 |
|
|
2023
Q2 | $17.1M | Buy |
+479,532
| New | +$17.2M | 6.04% | 9 |
|
|
2022
Q4 | – | Sell |
-790,600
| Closed | -$23.3M | – | 57 |
|
|
2022
Q3 | $23.3M | Buy |
+790,600
| New | +$30M | 9.92% | 3 |
|
|
2021
Q2 | – | Sell |
-206,000
| Closed | -$9.19M | – | 86 |
|
|
2021
Q1 | $9.19M | Buy |
+206,000
| New | +$9.35M | 1.92% | 16 |
|
|
2020
Q4 | – | Sell |
-165,310
| Closed | -$7.78M | – | 101 |
|
|
2020
Q3 | $7.78M | Buy |
+165,310
| New | +$8.28M | 1.73% | 24 |
|
|
2020
Q1 | – | Sell |
-163,764
| Closed | -$9.62M | – | 77 |
|
|
2019
Q4 | $9.62M | Buy |
+163,764
| New | +$9.11M | 2.92% | 14 |
|
|
2019
Q3 | – | Sell |
-303,600
| Closed | -$15.2M | – | 77 |
|
|
2019
Q2 | $15.2M | Buy |
303,600
+94,000
| +45% | +$4.72M | 4.66% | 5 |
|
|
2019
Q1 | $10.9M | Buy |
+209,600
| New | +$10.5M | 3.34% | 7 |
|
|
2018
Q4 | – | Sell |
-291,168
| Closed | -$14.6M | – | 77 |
|
|
2018
Q3 | $14.6M | Buy |
+291,168
| New | +$14.8M | 6.24% | 1 |
|
|
2018
Q1 | – | Sell |
-260,658
| Closed | -$11.6M | – | 37 |
|
|
2017
Q4 | $11.6M | Buy |
260,658
+123,303
| +90% | +$5.7M | 10.89% | 2 |
|
|
2017
Q3 | $6.97M | Buy |
137,355
+46,865
| +52% | +$2.38M | 5.58% | 8 |
|
|
2017
Q2 | $4.88M | Sell |
90,490
-118,720
| -57% | -$6.33M | 3.7% | 15 |
|
|
2017
Q1 | $11M | Buy |
209,210
+64,561
| +45% | +$3.28M | 8.49% | 4 |
|
|
2016
Q4 | $6.96M | Buy |
+144,649
| New | +$7.15M | 7.26% | 5 |
|
|
2015
Q3 | – | Sell |
-204,000
| Closed | -$10.6M | – | 41 |
|
|
2015
Q2 | $10.6M | Buy |
+204,000
| New | +$11.5M | 8.57% | 3 |
|
|
2015
Q1 | – | Sell |
-168,297
| Closed | -$8.99M | – | 36 |
|
|
2014
Q4 | $8.99M | Buy |
+168,297
| New | +$9.42M | 7.06% | 3 |
|
Other funds holding GSK
JEST
